XML 40 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Class A [Member]
Common Stock [Member]
Class B [Member]
Common Stock [Member]
Class B [Member]
Beginning balance at Dec. 31, 2018 $ 54,720 $ (7,347) $ 308,075 $ 356,082 $ 112 $ 522  
Beginning balance (in shares) at Dec. 31, 2018         2,615,000 12,254,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (income) 0 0 2,748 2,748 $ 0 $ 0  
Foreign currency translation adjustment, net of tax 0 307 0 307 0 0  
Change in unrealized gain (loss) on investments, net of tax 0 8,456 0 8,456 0 0  
Common stock dividends 0 0 (1,493) (1,493) 0 0  
Repurchase of common stock (108) 0 (359) (468) $ 0 $ (1)  
Repurchase of common stock (in shares)         0 (25,000)  
Restricted stock grants 437 0 0 438 $ 0 $ 1  
Restricted stock grants (in shares)         0 20,000  
Ending balance at Mar. 31, 2019 55,049 1,416 308,971 366,070 $ 112 $ 522  
Ending balance (in shares) at Mar. 31, 2019         2,615,000 12,249,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of the adoption of updated accounting guidance for credit losses, net of tax | ASU 2016-13 [Member] 0 0 (12,281) (12,281) $ 0 $ 0  
Beginning balance at Dec. 31, 2019 53,349 9,369 300,988 364,316 $ 111 $ 499  
Beginning balance (in shares) at Dec. 31, 2019         2,603,000 11,676,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (income) 0 0 (22,156) (22,156) $ 0 $ 0  
Foreign currency translation adjustment, net of tax 0 (687) 0 (687) 0 0  
Change in unrealized gain (loss) on investments, net of tax 0 (20,861) 0 (20,861) 0 0  
Common stock dividends 0 0 (1,426) (1,426) 0 0  
Repurchase of common stock (563) 0 (1,214) (1,782) $ 0 $ (5)  
Repurchase of common stock (in shares)         0 (127,000) (126,764)
Restricted stock grants 259 0 0 260 $ 0 $ 1  
Restricted stock grants (in shares)         0 31,000  
Ending balance at Mar. 31, 2020 $ 53,045 $ (12,179) $ 263,911 $ 305,383 $ 111 $ 495  
Ending balance (in shares) at Mar. 31, 2020         2,603,000 11,580,000